On July 10, 2026, Germany's Bundestag is set to vote on a healthcare cost-cutting package aimed at reducing public health expenditures starting in the 2027 budget. The proposal includes measures such as increased patient co-payments for prescriptions and stricter regulations on spousal co-insurance within the statutory health insurance system. These changes target various sectors including doctors' offices, hospitals, pharmacies, and the pharmaceutical industry. Despite attempts to challenge the legislation through the Constitutional Court due to concerns over insufficient parliamentary scrutiny of last-minute amendments, these efforts were unsuccessful. While the package is anticipated to pass in the Bundestag, potential resistance remains possible in the Bundesrat, Germany's upper legislative chamber. Additionally, this policy has sparked protests among healthcare workers nationwide.
Bias read (Center): The article presents the proposed healthcare cost-cutting measures and their implications neutrally, without overtly favoring any particular political stance. It outlines both the government's plans and the opposition, including legal challenges and public protests, providing balanced information.




